Russell Investments Group
KNSA icon

Russell Investments Group’s Kiniksa Pharmaceuticals KNSA Stock Holding History

Russell Investments Group’s Portfolio KNSA Stock Details KNSA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$224K Buy
3,506
+3,384
+2,774% +$176K ﹤0.01% 3133
2026
Q1 		$5.87K Sell
122
-3,072
-96% -$136K ﹤0.01% 3872
2025
Q4 		$131K Sell
3,194
-45,988
-94% -$1.84M ﹤0.01% 2963
2025
Q3 		$1.91M Sell
49,182
-11,913
-19% -$387K ﹤0.01% 1888
2025
Q2 		$1.7M Sell
61,095
-22,056
-27% -$561K ﹤0.01% 1799
2025
Q1 		$1.88M Buy
83,151
+83,126
+332,504% +$1.71M ﹤0.01% 1735
2024
Q4 		$495 Sell
25
-32
-56% -$730 ﹤0.01% 3611
2024
Q3 		$1.42K Buy
+57
New +$1.39K ﹤0.01% 3438
2023
Q4 		– Sell
-20,814
Closed -$363K – 3258
2023
Q3 		$363K Buy
+20,814
New +$351K ﹤0.01% 2332
2023
Q2 		– Sell
-31,639
Closed -$340K – 3494
2023
Q1 		$340K Buy
31,639
+8,025
+34% +$106K ﹤0.01% 2371
2022
Q4 		$354K Buy
23,614
+3,253
+16% +$47.4K ﹤0.01% 2409
2022
Q3 		$261K Buy
+20,361
New +$232K ﹤0.01% 2473
2022
Q1 		– Sell
-10,740
Closed -$126K – 2851
2021
Q4 		$126K Sell
10,740
-3,699
-26% -$45.5K ﹤0.01% 2806
2021
Q3 		$163K Sell
14,439
-250
-2% -$3.26K ﹤0.01% 2810
2021
Q2 		$204K Sell
14,689
-1,328
-8% -$20.2K ﹤0.01% 2904
2021
Q1 		$296K Buy
16,017
+13,817
+628% +$283K ﹤0.01% 2719
2020
Q4 		$38K Hold
2,200
– – ﹤0.01% 2945
2020
Q3 		$33K Hold
2,200
– – ﹤0.01% 3110
2020
Q2 		$56K Hold
2,200
– – ﹤0.01% 2979
2020
Q1 		$34K Buy
+2,200
New +$34.4K ﹤0.01% 2907

Other funds holding KNSA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
RHJA
Rice Hall James & Associates San Diego, California $2.05B AUM 43.16% 1-Year Est. Return
Pictet Asset Management
Pictet Asset Management Carouge, Switzerland $105B AUM 38.07% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $178B AUM 37.23% 1-Year Est. Return
SG Americas Securities
SG Americas Securities New York $179B AUM 65.34% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return

Russell Investments Group's KNSA Position: Q2 2026 in Review

Russell Investments Group increased its Kiniksa Pharmaceuticals (KNSA) stake by 2,774% in Q2 2026, buying an estimated $176K and bringing the position to 3,506 shares worth $224K. The position accounts for ﹤0.01% of the portfolio, ranked #3133.

Russell Investments Group first reported a position in KNSA in Q1 2020 and has held it in 20 quarters since. The position peaked at $1.91M in Q3 2025. 103 funds tracked by Wall St. Rank hold KNSA as of Q2 2026.

  • Russell Investments Group held 3,506 shares of Kiniksa Pharmaceuticals worth $224K as of Q2 2026.
  • Russell Investments Group bought 3,384 Kiniksa Pharmaceuticals shares in Q2 2026, an estimated $176K.
  • Kiniksa Pharmaceuticals made up ﹤0.01% of Russell Investments Group's portfolio in Q2 2026, its #3133 holding.
  • Russell Investments Group first reported a position in Kiniksa Pharmaceuticals in Q1 2020 and has held it in 20 quarters since.
  • Russell Investments Group's Kiniksa Pharmaceuticals position peaked at $1.91M in Q3 2025.
  • 103 funds tracked by Wall St. Rank held Kiniksa Pharmaceuticals as of Q2 2026.

Based on Russell Investments Group's 13F filing for Q2 2026, filed 6 Aug 2026.